AU2003239211A1 - Compositions and methods for site-specific recombination and expression - Google Patents

Compositions and methods for site-specific recombination and expression

Info

Publication number
AU2003239211A1
AU2003239211A1 AU2003239211A AU2003239211A AU2003239211A1 AU 2003239211 A1 AU2003239211 A1 AU 2003239211A1 AU 2003239211 A AU2003239211 A AU 2003239211A AU 2003239211 A AU2003239211 A AU 2003239211A AU 2003239211 A1 AU2003239211 A1 AU 2003239211A1
Authority
AU
Australia
Prior art keywords
expression
compositions
site
methods
specific recombination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003239211A
Other versions
AU2003239211A8 (en
Inventor
Naoki Goshima
Aya Miura
Nobuo Nomura
Ryohei Satoh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Institute of Advanced Industrial Science and Technology AIST
Life Technologies Corp
Original Assignee
Invitrogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Invitrogen Corp filed Critical Invitrogen Corp
Publication of AU2003239211A8 publication Critical patent/AU2003239211A8/en
Publication of AU2003239211A1 publication Critical patent/AU2003239211A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
AU2003239211A 2003-05-15 2003-06-12 Compositions and methods for site-specific recombination and expression Abandoned AU2003239211A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47044803P 2003-05-15 2003-05-15
US60/470,448 2003-05-15
PCT/US2003/018219 WO2004104194A1 (en) 2003-05-15 2003-06-12 Compositions and methods for site-specific recombination and expression

Publications (2)

Publication Number Publication Date
AU2003239211A8 AU2003239211A8 (en) 2004-12-13
AU2003239211A1 true AU2003239211A1 (en) 2004-12-13

Family

ID=33476708

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003239211A Abandoned AU2003239211A1 (en) 2003-05-15 2003-06-12 Compositions and methods for site-specific recombination and expression

Country Status (2)

Country Link
AU (1) AU2003239211A1 (en)
WO (1) WO2004104194A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1229113A3 (en) * 1995-06-07 2002-11-27 Invitrogen Corporation Recombinational cloning using engineered recombination sites
NZ504214A (en) * 1997-10-24 2003-06-30 Invitrogen Corp Recombination cloning using nucleic acids having recombination sites

Also Published As

Publication number Publication date
WO2004104194A1 (en) 2004-12-02
AU2003239211A8 (en) 2004-12-13

Similar Documents

Publication Publication Date Title
EP1518918A2 (en) Fuels compositions and methods for using same
HK1215046A1 (en) Methods and compositions for targeted cleavage and recombination
AP2089A (en) Compositions and methods for combination antiviraltherapy
AU2003262747A1 (en) Compounds, compositions, and methods
AU2003236527A1 (en) Compounds, compositions, and methods
AU2003265242A1 (en) Compounds, compositions, and methods
AU2003248862A1 (en) Compositions and fabrication methods for hardmetals
AU2003270015A1 (en) Compounds, compositions, and methods
AU2003254898A1 (en) Fragrance composition
GB0411940D0 (en) Methods and compositions
EP1503993A4 (en) Compounds, methods and compositions
EP1701725A4 (en) Methods and compositions
AU2003299612A1 (en) Compounds, compositions and methods
AU2003267644A1 (en) Dental compositions and methods
EP1511734A4 (en) Compounds, compositions, and methods
AU2003256805A1 (en) Compounds compositions and methods
AU2003291869A1 (en) Fuel compositions
AU2003266815A1 (en) Immunoglobulin compositions and methods
AU2003290507A1 (en) Compounds, compositions and methods
AU2003277079A1 (en) Compounds, compositions, and methods
AU2003269904A1 (en) Antigen-polymer compositions
AU2003300031A1 (en) Compounds, compositions, and methods
AU2003267169A1 (en) Compounds, compositions and methods
AU2003255721A1 (en) Perfume compositions
AU2003212866A1 (en) Controlled release compositions and methods for using same

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 19, NO 3, PAGE(S) 170 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME INVITROGEN CORPORATION, APPLICATION NO. 2003239211, UNDER INID (71) CORRECT THE NAME TO READ NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (AIST), JAPAN BIOLOGICAL INFORMATION RESEARCH CENTER (JBIRC); INVITROGEN CORPORATION

MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase